We provide total solutions that enhance the value of life.
Cell and Gene Therapy Research
Cell and gene therapy (CGT) is an advanced class of biopharmaceuticals that directly corrects or replaces damaged cells or genes to treat the underlying causes of disease. By precisely reprogramming biological systems, it represents a next‑generation medical paradigm for overcoming intractable diseases.
Addressing the root causes of disease
Overcoming the limitations of treatment for intractable and rare diseases, including cancer, genetic disorders, and immune‑related diseases
Patient‑centered, personalized precision therapies
Long‑term and sustained therapeutic effects
Establishing a new treatment paradigm based on the reprogramming of biological functions
Focus areas
Stem Cells
Utilization of stem cells from diverse sources
Securing a broad range of sources, including embryonic and adult tissue-derived cells
Dementia
Sarcopenia
Regeneration
Pulmonary fibrosis
Immune Cells
Enhancement and activation of patient-specific immune systems
Maximization of therapeutic efficacy
Oncology
Chronic fatigue
Autoimmune diseases
Extracellular Vesicles
Inheriting the therapeutic effects of stem cell-based therapies
Efficient next-generation drug delivery systems
Cognitive function improvement
Regeneration
Anti-aging
Gene Therapy
Treatment of the underlying causes of disease
Precise targeting and long-term therapeutic effects
Intractable diseases
Genetic disorders
Anti-aging
Stem Cells
Utilization of stem cells from diverse sources
Securing a broad range of sources, including embryonic and adult tissue-derived cells
Dementia
Sarcopenia
Regeneration
Pulmonary fibrosis
Immune Cells
Enhancement and activation of patient-specific immune systems
Maximization of therapeutic efficacy
Oncology
Chronic fatigue
Autoimmune diseases
Extracellular Vesicles
Inheriting the therapeutic effects of stem cell-based therapies
Efficient next-generation drug delivery systems
Cognitive function improvement
Regeneration
Anti-aging
Gene Therapy
Treatment of the underlying causes of disease
Precise targeting and long-term therapeutic effects
Intractable diseases
Genetic disorders
Anti-aging
Core Competency
Defining new paradigms in treatment through advanced technology and differentiated research
Core Competency 01
Stem Cell and Immune Cell-Based Technologies
We possess integrated infrastructure covering research and development (R&D), translational research, and GMP manufacturing for the isolation, culture, and cell line establishment of stem cells (iPSC, ES, UC/AD-MSC) derived from diverse tissues, as well as immune cells. Through this, we have secured end-to-end development capabilities for cell therapies.
Core Competency 02
Next-Generation Bio Platform
We have an integrated technology platform that enables the production of organoids (3D models), exosomes, and cell-derived secretomes from stem cells for use in therapeutic development, efficacy evaluation, and cosmetic ingredients. Through this platform, we are expanding into new modalities in the field of regenerative medicine.
Core Competency 03
Next-Generation Gene Editing Capabilities
By applying gene editing technologies, we maximize the therapeutic efficacy of stem cells and immune cells and develop next-generation exosome-based therapeutics carrying specific functional genes. In addition, through strategic partnerships with a research institute in Indonesia, we conduct global collaborative research to identify novel targets and expand our gene therapy pipeline.